Jaisim Shah's Net Worth

$743 Thousand

Estimate Recalculated Nov 1, 2024 11:40AM EST

Who is Jaisim Shah

Jaisim Shah does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sorrento Therapeutics, Inc., CYTRX CORP, PROTEIN DESIGN LABS INC/DE, Scilex Holding Co, and FACET BIOTECH CORP.

SEC CIK

Jaisim Shah's CIK is 0001242133

Past Insider Trading and Trends

2007 was Jaisim Shah's most active year for acquiring shares with 15 total transactions. Jaisim Shah's most active month to acquire stocks was the month of March. 2007 was Jaisim Shah's most active year for disposing of shares, totalling 28 transactions. Jaisim Shah's most active month to dispose stocks was the month of March. 2015 saw Jaisim Shah paying a total of $312,673.50 for 132,189 shares, this is the most they've acquired in one year. In 2007 Jaisim Shah cashed out on 103,040 shares for a total of $1,274,280.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sorrento Therapeutics, Inc.

Investor
Updated Aug 30, 2021
Form 4
250.00K
Aug 30, 2021
250.00K
Grant
Aug 30
Form 4
100.00K
Jun 15, 2020
100.00K
Grant
Jun 15
Form 4
70.00K
Apr 23, 2019
70.00K
Grant
Apr 19
Form 4
35.00K
Nov 27, 2018
35.00K
Grant
Nov 26
Form 4/A
35.00K
Sep 18, 2017
35.00K
Grant
Sep 15
Form 4
35.00K
Sep 15, 2017
35.00K
Grant
Sep 15
Form 4
9.75%
10.00K
$1.79
$17.90K
Jun 15, 2017
112.63K
Purchase
Jun 15
Form 4
10.80%
10.00K
$5.15
$51.50K
Feb 03, 2017
102.63K
Purchase
Feb 03
Form 4
12.96%
35.00K
Jul 12, 2016
305.00K
Grant
Jul 11
Form 4
41.55%
27.19K
$11.50
$312.67K
Aug 05, 2015
92.63K
Purchase
Aug 03
Form 4
10.20%
25.00K
Jun 08, 2015
270.00K
Grant
Jun 04
Form 4
48.48%
80.00K
Feb 26, 2015
245.00K
Grant
Feb 24
Form 4
17.86%
25.00K
Sep 22, 2014
165.00K
Grant
Sep 18
Form 4
1.55%
1.00K
$8.65
$8.65K
Nov 26, 2013
65.44K
Purchase
Nov 25
Form 4
1.58%
1.00K
$9.00
$9.00K
Nov 20, 2013
64.44K
Purchase
Nov 19
Form 4
133.33%
80.00K
Oct 31, 2013
140.00K
Grant
Oct 29
Form 3
Sep 20, 2013
Showing 17 results

CYTRX CORP

Sr. VP - Business Development
Updated May 05, 2009
Form 3
May 05, 2009
Showing 1 results

PROTEIN DESIGN LABS INC/DE

SVP, Mktg & Bus. Affairs
Updated Apr 30, 2008
Form 4
$8.54
$10.68K
Apr 30, 2008
16.13K
Options
Apr 28
Form 4
30.00K
Aug 17, 2007
30.00K
Grant
Aug 15
Form 4
-30.81%
-16.44K
$20.68
-$175.15K
Apr 30, 2007
36.92K
Sale
ScheduledApr 30
Form 4
-31.29%
-15.00K
$19.66
-$160.18K
Apr 24, 2007
32.94K
Sale
ScheduledApr 23
Form 4
-49.04%
-20.08K
$16.18
-$293.83K
Apr 17, 2007
20.86K
Sale
ScheduledApr 11 - Apr 13
Form 4
2,170.14%
31.25K
Jul 24, 2006
32.69K
Grant
Jul 20
Form 4
-45.45%
-5.00K
$21.65
-$93.55K
Jan 11, 2006
6.00K
Sale
ScheduledJan 09
Form 4
-58.72%
-17.08K
$19.39
-$248.46K
Aug 05, 2005
12.01K
Sale
ScheduledAug 03
Form 4
37.00K
Jul 15, 2005
37.00K
Grant
Jul 13
Form 4
27.00K
Jul 26, 2004
27.00K
Grant
Jul 23
Form 4
-16.22%
-5.00K
$19.65
-$73.55K
Apr 28, 2004
25.83K
Sale
ScheduledApr 26
Form 4/A
-13.79%
-4.80K
$12.29
-$58.99K
Mar 18, 2004
30.00K
Options
Mar 05
Form 4
18.44%
4.80K
$15.47
-$2.02K
Mar 08, 2004
30.83K
Sell-Options
Mar 05
Form 4/A
-0.56%
-200.00
$15.48
-$5.00K
Mar 05, 2004
35.63K
Sale
Feb 26
Form 4
-0.84%
-300.00
$15.48
-$7.51K
Feb 27, 2004
35.53K
Sale
Feb 26
Form 4
-12.25%
-5.00K
$14.97
-$115.00K
Feb 19, 2004
35.83K
Sale
Feb 18
Form 4
Jul 01, 2003
Showing 17 results

Scilex Holding Co

See Remarks
Updated Oct 29, 2024
Form 4
41.38%
32.00K
$0.99
$31.67K
Oct 29, 2024
265.22K
Purchase
Oct 29
Form 4
63.38%
30.00K
$0.99
$29.75K
Oct 17, 2024
233.22K
Purchase
Oct 16
Form 4
$1.73
$24.22K
Jun 20, 2024
8.08M
Options
Jun 20
Form 4
$1.41
$47.00K
Jun 14, 2024
355.88K
Options
Jun 14
Form 4
881.50%
140.00K
$0.87
$121.95K
May 17, 2024
155.88K
Purchase
May 16 - May 17
Form 4
200.00K
Oct 05, 2023
200.00K
Grant
Oct 04
Form 4
1.70M
Jan 17, 2023
1.70M
Grant
Jan 17
Form 3
Nov 15, 2022
Showing 8 results

FACET BIOTECH CORP

SVP, Chief Business Officer
Updated Dec 22, 2008
Form 3
Dec 22, 2008
2.13K
Showing 1 results